The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126048272 12604827 2 F 2013 20160815 20160728 20160826 PER US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-47460BP BOEHRINGER INGELHEIM 58.89 YR M Y 0.00000 20160827 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126048272 12604827 1 PS SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Respiratory (inhalation) 18 MCG 507710A,14C3232 21395 18 UG INHALATION POWDER, HARD CAPSULE QD
126048272 12604827 2 C LEXAPRO ESCITALOPRAM OXALATE 1 Oral 20 MG 0 20 MG TABLET QD
126048272 12604827 3 C WELLBUTRIN BUPROPION HYDROCHLORIDE 1 Oral 150 MG 0 150 MG TABLET QD
126048272 12604827 4 C PREDNISONE. PREDNISONE 1 Oral STRENGTH:5 MG EVERY OTHER DAY AND 7.5 MG ON OPPOSITE DAYS 0 TABLET
126048272 12604827 5 C PREDNISONE. PREDNISONE 1 Unknown FORMULATION: TABLET 0
126048272 12604827 6 C AMLODIPINE BESYLATE. AMLODIPINE BESYLATE 1 Oral 10 MG 0 10 MG TABLET QD
126048272 12604827 7 C ADVAIR HFA FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Respiratory (inhalation) 2 ANZ 0 NEBULISER LIQUID BID
126048272 12604827 8 C ADVAIR HFA FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 0
126048272 12604827 9 C OXYMORPHONE OXYMORPHONE 1 Oral 80 MG 0 40 MG TABLET BID
126048272 12604827 10 C OXYMORPHONE OXYMORPHONE 1 Oral 40 MG 0 10 MG TABLET
126048272 12604827 11 C ALBUTEROL. ALBUTEROL 1 Respiratory (inhalation) 3 ANZ 0 ORAL SOLUTION TID
126048272 12604827 12 C INDOCIN INDOMETHACININDOMETHACIN SODIUM 1 Oral 50 MG 0 25 MG CAPSULE
126048272 12604827 13 C DIAZEPAM. DIAZEPAM 1 Oral 30 MG 0 10 MG TABLET
126048272 12604827 14 C ZOLPIDEM ZOLPIDEMOLPIDEM TARTRATE 1 Oral 10 MG 0 10 MG TABLET QD
126048272 12604827 15 C OXYGEN. OXYGEN 1 Unknown DOSE PER APPLICATION: 4 LITERS 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126048272 12604827 1 Chronic obstructive pulmonary disease
126048272 12604827 2 Depression
126048272 12604827 3 Depression
126048272 12604827 4 Sarcoidosis
126048272 12604827 6 Hypertension
126048272 12604827 7 Sarcoidosis
126048272 12604827 8 Chronic obstructive pulmonary disease
126048272 12604827 9 Arthralgia
126048272 12604827 10 Back pain
126048272 12604827 11 Product used for unknown indication
126048272 12604827 12 Gout
126048272 12604827 13 Product used for unknown indication
126048272 12604827 14 Sleep disorder
126048272 12604827 15 Product used for unknown indication

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
126048272 12604827 Fall
126048272 12604827 Head injury
126048272 12604827 Laceration
126048272 12604827 Mouth injury
126048272 12604827 Muscular weakness
126048272 12604827 Oral contusion
126048272 12604827 Product quality issue
126048272 12604827 Therapeutic response unexpected

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126048272 12604827 1 2010 0
126048272 12604827 7 201607 0